Long-Term Clinical Results of IGRT in Prostate Cancer Treatment

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73602241" target="_blank" >RIV/61989592:15110/20:73602241 - isvavai.cz</a>
Result on the web
<a href="https://www.linkos.cz/files/klinicka-onkologie/468/5695.pdf" target="_blank" >https://www.linkos.cz/files/klinicka-onkologie/468/5695.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.14735/amko202049" target="_blank" >10.14735/amko202049</a>

Result language
angličtina
Original language name
Long-Term Clinical Results of IGRT in Prostate Cancer Treatment
Original language description
Background: The combination of intensity modulated radiation therapy (IMRT) and image guided radiotherapy (IGRT) plays a significant role in sparing normal tissue during prostate cancer treatment. We report the clinical outcomes of 260 patients treated with high-dose IGRT as well as the toxicity of high-dose IGRT in these patients Materials and methods: From September 2008 to February 2012, 260 men with clinically localized prostate cancer underwent radical radiotherapy. Two hundred patients were treated with IMRT (78 Gy in 39 fractions) to the prostate and base of seminal vesicles using an adaptive protocol combining cone-beam computed tomography (CBCT) and kilovoltage image matching with individualized safety margin calculation. Sixty patients underwent treatment with the same prescribed dose using RapidArc with a reduced safety margin of 6 mm and daily online matching using CBCT.
Czech name
—
Czech description
—

Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30204 - Oncology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)